Comparison of technetium-99m teboroxime tomography with automated quantitative coronary arteriography and thallium-201 tomographic imaging

Department of Cardiology, University of Texas Medical School, Houston 77030.

Technetium-99m (Tc-99m) teboroxime is a new perfusion tracer that is highly extracted and rapidly cleared by the myocardium. To determine the feasibility of Tc-99m teboroxime imaging in the diagnosis of patients with suspected coronary artery disease, 30 patients underwent single photon emission computed tomography imaging with Tc-99m teboroxime (25.2 +/- 1 mCi) at peak exercise and again 60 min later at rest. All patients underwent either a thallium stress test (n = 26) or automated quantitative coronary arteriography (n = 25), or both, without intervening revascularization or infarction. Images were reviewed by two investigators who had no knowledge of clinical data. Coronary lesions with greater than or equal to 50% diameter narrowing by quantitative coronary arteriography were considered significant. Both thallium and Tc-99m teboroxime detected disease in all patients with two or three vessel disease. One vessel disease was detected with Tc-99m teboroxime in 9 of 10 patients and with thallium in 8 of 10 (p = NS). In patients without angiographically significant disease. Tc-99m teboroxime demonstrated normal perfusion in six of eight patients and thallium in three of five (p = NS). Overall, when presence or absence of disease detected by Tc-99m teboroxime or thallium was compared with quantitative coronary arteriography, there was no difference between Tc-99m teboroxime and thallium. These results suggest that Tc-99m teboroxime is comparable to thallium as an imaging agent. The rapid biologic half-life, 5.3 min, allows studies to be completed in 60 to 90 min.

This article has been cited by other articles:

				R. M. Fleming and G. M. Harrington What Is the Relationship Between Myocardial Perfusion Imaging and Coronary Artery Disease Risk Factors and Markers of Inflammation? Angiology, March 1, 2008; 59(1): 16 - 25. [Abstract] [PDF]

				R. O. Bonow High-speed myocardial perfusion imaging: dawn of a new era in nuclear cardiology? J. Am. Coll. Cardiol. Img., March 1, 2008; 1(2): 164 - 166. [Full Text] [PDF]

				R. M. Fleming The Effect of Ephedra and High Fat Dieting: A Cause for Concern!: A Case Report Angiology, February 1, 2007; 58(1): 102 - 105. [Abstract] [PDF]

				F. C. Aepfelbacher, S. B. Yeon, K. K. L. Ho, J. A. Parker, and P. G. Danias ECG-Gated 99mTc Single-Photon Emission CT for Assessment of Right Ventricular Structure and Function: Is the Information Provided Similar to Echocardiography? Chest, July 1, 2003; 124(1): 227 - 232. [Abstract] [Full Text] [PDF]

				R. M. Fleming and L. D. Boyd High-Dose Dipyridamole and Gated Sestamibi SPECT Imaging Provide Diagnostic Resting and Stress Ejection Fractions Useful for Predicting Extent of Coronary Artery Disease Angiology, July 1, 2002; 53(4): 415 - 421. [Abstract] [PDF]

				R. M. Fleming A Tete-a-Tete Comparison of Ejection Fraction and Regional Wall Motion Abnormalities as Measured by Echocardiography and Gated Sestamibi SPECT Angiology, May 1, 2002; 53(3): 313 - 321. [Abstract] [PDF]

				R. J. Gibbons, K. Chatterjee, J. Daley, J. S. Douglas, S. D. Fihn, J. M. Gardin, M. A. Grunwald, D. Levy, B. W. Lytle, R. A. O'Rourke, et al. ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina) J. Am. Coll. Cardiol., June 1, 1999; 33(7): 2092 - 2197. [Full Text] [PDF]

				K. E. Fleischmann, M. G. M. Hunink, K. M. Kuntz, and P. S. Douglas Exercise Echocardiography or Exercise SPECT Imaging?: A Meta-analysis of Diagnostic Test Performance JAMA, September 9, 1998; 280(10): 913 - 920. [Abstract] [Full Text] [PDF]

				R. M. Fleming, D. M. Fleming, and R. Gaede Training Physicians and Health Care Providers to Accurately Read Coronary Arteriograms A Training Program Angiology, April 1, 1996; 47(4): 349 - 359. [Abstract] [PDF]

				R. M. Fleming, C. H. Rose, and K. M. Feldmann Comparing a High-Dose Dipyridamole SPECT Imaging Protocol with Dobutamine and Exercise Stress Testing Protocols Angiology, July 1, 1995; 46(7): 547 - 556. [Abstract] [PDF]